Los puntos clave no están disponibles para este artículo en este momento.
Caitlin Shannon1 Fax: +1 212 448 1260; E-mail: cataspencer@ gmail.com 2E-mail: bwinikoff@ gynuity.org ‘The promise of early pregnancy termination with mifepristone and misoprostol is often compromised by overly medicalized practices and regulations ... that are barriers to greater acceptability, access and availability.’
Shannon et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: